Ms Natalie Johnston

Principal at 4BIO Capital

Speaker

Natalie joined the 4BIO Capital as an Analyst in 2019. She works in the investment team sourcing and accessing deals alongside acting as a Board Observer for Ray Therapeutics and ViaNautis. Before joining the firm, she worked within financial services at Gerson Lehrman Group providing diligence assistance to investment banks, hedge funds and venture capital firms operating in the healthcare sector. Natalie holds PhD from Imperial College London, and a BSc in Biochemistry from the University of Glasgow